272 related articles for article (PubMed ID: 22092168)
41. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
[TBL] [Abstract][Full Text] [Related]
42. Duration of aortic cross-clamping during elective open abdominal aortic aneurysm repair operations and postoperative cardiac/renal function.
Georgakis P; Paraskevas KI; Bessias N; Mikhailidis DP; Andrikopoulos V; Katsouli-Liapis I
Int Angiol; 2010 Jun; 29(3):244-8. PubMed ID: 20502411
[TBL] [Abstract][Full Text] [Related]
43. Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study.
Karahan SC; Koramaz I; Altun G; Uçar U; Topbaş M; Menteşe A; Kopuz M
Eur Surg Res; 2010; 44(1):30-6. PubMed ID: 19955769
[TBL] [Abstract][Full Text] [Related]
44. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
[TBL] [Abstract][Full Text] [Related]
45. N-acetylcysteine as an additive to crystalloid cardioplegia increased oxidative stress capacity in CABG patients.
Vento AE; Nemlander A; Aittomäki J; Salo J; Karhunen J; Rämö OJ
Scand Cardiovasc J; 2003 Dec; 37(6):349-55. PubMed ID: 14668186
[TBL] [Abstract][Full Text] [Related]
46. Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study.
Schmidt SC; Hamann S; Langrehr JM; Höflich C; Mittler J; Jacob D; Neuhaus P
J Hepatobiliary Pancreat Surg; 2007; 14(5):484-92. PubMed ID: 17909718
[TBL] [Abstract][Full Text] [Related]
47. N-Acetylcysteine does not artifactually lower plasma creatinine concentration.
Haase M; Haase-Fielitz A; Ratnaike S; Reade MC; Bagshaw SM; Morgera S; Dragun D; Bellomo R
Nephrol Dial Transplant; 2008 May; 23(5):1581-7. PubMed ID: 18202091
[TBL] [Abstract][Full Text] [Related]
48. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
[TBL] [Abstract][Full Text] [Related]
49. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study.
Ozaydin M; Peker O; Erdogan D; Kapan S; Turker Y; Varol E; Ozguner F; Dogan A; Ibrisim E
Eur Heart J; 2008 Mar; 29(5):625-31. PubMed ID: 18263874
[TBL] [Abstract][Full Text] [Related]
50. Cytokines, their genetic polymorphisms, and outcome after abdominal aortic aneurysm repair.
Bown MJ; Horsburgh T; Nicholson ML; Bell PR; Sayers RD
Eur J Vasc Endovasc Surg; 2004 Sep; 28(3):274-80. PubMed ID: 15288631
[TBL] [Abstract][Full Text] [Related]
51. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis.
Baker WL; Anglade MW; Baker EL; White CM; Kluger J; Coleman CI
Eur J Cardiothorac Surg; 2009 Mar; 35(3):521-7. PubMed ID: 19147369
[TBL] [Abstract][Full Text] [Related]
52. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
[TBL] [Abstract][Full Text] [Related]
53. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
[TBL] [Abstract][Full Text] [Related]
54. Myocardial injury in major aortic surgery.
Hafez HM; Berwanger CS; McColl A; Richmond W; Wolfe JH; Mansfield AO; Stansby G
J Vasc Surg; 2000 Apr; 31(4):742-50. PubMed ID: 10753282
[TBL] [Abstract][Full Text] [Related]
55. Dopexamine hydrochloride does not modify hemodynamic response or tissue oxygenation or gut permeability during abdominal aortic surgery.
McGinley J; Lynch L; Hubbard K; McCoy D; Cunningham AJ
Can J Anaesth; 2001 Mar; 48(3):238-44. PubMed ID: 11305823
[TBL] [Abstract][Full Text] [Related]
56. Comparison of serum cardiac specific biomarker release after non-cardiac thoracic surgery.
Muley T; Kurz M; Männle C; Alekozai A; Winteroll S; Dienemann H; Schmidt W; Pfannschmidt J
Clin Lab; 2011; 57(11-12):925-32. PubMed ID: 22239023
[TBL] [Abstract][Full Text] [Related]
57. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
[TBL] [Abstract][Full Text] [Related]
58. Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.
Molnar Z; Szakmany T; Koszegi T
Intensive Care Med; 2003 May; 29(5):749-55. PubMed ID: 12682719
[TBL] [Abstract][Full Text] [Related]
59. Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery.
Orhan G; Yapici N; Yuksel M; Sargin M; Senay S; Yalçin AS; Aykaç Z; Aka SA
Heart Vessels; 2006 Jan; 21(1):42-7. PubMed ID: 16440148
[TBL] [Abstract][Full Text] [Related]
60. Protective effects of N-acetylcysteine on aluminum phosphide-induced oxidative stress in acute human poisoning.
Tehrani H; Halvaie Z; Shadnia S; Soltaninejad K; Abdollahi M
Clin Toxicol (Phila); 2013 Jan; 51(1):23-8. PubMed ID: 23148565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
